Potential competitor in the B-cell lymphoma space: | IONS Message Board Posts

Ionis Pharmaceuticals, Inc.

  IONS website

IONS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  61532 of 61560  at  2/5/2021 3:19:01 PM  by

iyonwin


 In response to msg 40610 by  jetmanbash
view thread

Re: Potential competitor in the B-cell lymphoma space:

 TG Therapeutics initiated with a Buy at MLV & Co; tgt $9; killing cancer better (3.97)
MLV & Co initiates TGTX with a Buy and price target of $9. TGTX is an early/mid-stage oncology-focused biotech with two potential-best-in-class candidates, TG-1101 (in P2) and TGR-1202 (in P1), that target B-cell lymphomas. MLV projects ~$10B in combined 2033 WW sales, in a current $7B market that it thinks could grow several-fold over the next decades with the advent of new agents and the embrace of combination approaches.
--------------------------------------------------------------------------------------------------------------------
 
 
I didn't buy tgtx when the jman posted about it back in 2013 but I watched and waited and about a week ago pulled the trigger.
 
This approval for tgtx is a very nice one for LGND as it's a 6 to 9 percent royalty drug.
 
So I'm hoping the jman was corrent in tgtx getting to 10b in sales over the next 10 years or so as I'm sure a large part of that would be the newly approved drug.
 
BTW, tvtx also announced significant results a couple of days ago with plans to file for approval based on those results. And that is even a better royalty rate.
 
Things are definitely looking up for lgnd and it's happening a lot sooner than I thought. Sometime it's good to be wrong.
 
Thanks jman for putting tgtx on my watch list 8 years ago.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board








Financial Market Data provided by
.
Loading...